Logo image of CFM.MI

CROWDFUNDME SPA (CFM.MI) Stock Fundamental Analysis

BIT:CFM - Euronext Milan - IT0005353575 - Common Stock - Currency: EUR

1.52  -0.09 (-5.59%)

Fundamental Rating

3

CFM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 24 industry peers in the Interactive Media & Services industry. While CFM seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CFM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CFM has reported negative net income.
CFM had a positive operating cash flow in the past year.
In the past 5 years CFM always reported negative net income.
In multiple years CFM reported negative operating cash flow during the last 5 years.
CFM.MI Yearly Net Income VS EBIT VS OCF VS FCFCFM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -500K -1M -1.5M

1.2 Ratios

CFM has a Return On Assets of -20.28%. This is amonst the worse of the industry: CFM underperforms 80.77% of its industry peers.
CFM has a worse Return On Equity (-23.43%) than 69.23% of its industry peers.
Industry RankSector Rank
ROA -20.28%
ROE -23.43%
ROIC N/A
ROA(3y)-11.97%
ROA(5y)-22.78%
ROE(3y)-15.54%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
CFM.MI Yearly ROA, ROE, ROICCFM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 24.14%, CFM is doing worse than 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of CFM has declined.
CFM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.82%
CFM.MI Yearly Profit, Operating, Gross MarginsCFM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400 -500

More info and screens

5

2. Health

2.1 Basic Checks

CFM has about the same amout of shares outstanding than it did 1 year ago.
CFM has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CFM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CFM.MI Yearly Shares OutstandingCFM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
CFM.MI Yearly Total Debt VS Total AssetsCFM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

2.2 Solvency

CFM has an Altman-Z score of 1.88. This is not the best score and indicates that CFM is in the grey zone with still only limited risk for bankruptcy at the moment.
CFM has a Altman-Z score of 1.88. This is comparable to the rest of the industry: CFM outperforms 46.15% of its industry peers.
CFM has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
CFM's Debt to FCF ratio of 0.01 is amongst the best of the industry. CFM outperforms 92.31% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CFM is not too dependend on debt financing.
CFM has a better Debt to Equity ratio (0.00) than 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 1.88
ROIC/WACCN/A
WACCN/A
CFM.MI Yearly LT Debt VS Equity VS FCFCFM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M 3M

2.3 Liquidity

CFM has a Current Ratio of 1.10. This is a normal value and indicates that CFM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.10, CFM is doing worse than 65.38% of the companies in the same industry.
A Quick Ratio of 1.10 indicates that CFM should not have too much problems paying its short term obligations.
CFM has a Quick ratio of 1.10. This is in the lower half of the industry: CFM underperforms 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CFM.MI Yearly Current Assets VS Current LiabilitesCFM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CFM have decreased strongly by -27.81% in the last year.
Looking at the last year, CFM shows a very strong growth in Revenue. The Revenue has grown by 125.54%.
CFM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.19% yearly.
EPS 1Y (TTM)-27.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.12%
Revenue 1Y (TTM)125.54%
Revenue growth 3Y20.79%
Revenue growth 5Y31.19%
Sales Q2Q%34.58%

3.2 Future

The Earnings Per Share is expected to grow by 36.28% on average over the next years. This is a very strong growth
Based on estimates for the next years, CFM will show a quite strong growth in Revenue. The Revenue will grow by 19.71% on average per year.
EPS Next Y38.1%
EPS Next 2Y36.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.74%
Revenue Next 2Y19.71%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CFM.MI Yearly Revenue VS EstimatesCFM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
CFM.MI Yearly EPS VS EstimatesCFM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CFM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CFM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CFM.MI Price Earnings VS Forward Price EarningsCFM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CFM indicates a rather cheap valuation: CFM is cheaper than 88.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.73
EV/EBITDA N/A
CFM.MI Per share dataCFM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

CFM's earnings are expected to grow with 36.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CFM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWDFUNDME SPA

BIT:CFM (3/5/2025, 7:00:00 PM)

1.52

-0.09 (-5.59%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners45.93%
Ins Owner ChangeN/A
Market Cap2.60M
Analysts80
Price Target2.65 (74.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.6
P/FCF 8.73
P/OCF 8.91
P/B 0.84
P/tB 67.69
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.17
FCFY11.45%
OCF(TTM)0.17
OCFY11.23%
SpS0.95
BVpS1.82
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.28%
ROE -23.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.14%
FCFM 18.29%
ROA(3y)-11.97%
ROA(5y)-22.78%
ROE(3y)-15.54%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 1.88
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.12%
EPS Next Y38.1%
EPS Next 2Y36.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)125.54%
Revenue growth 3Y20.79%
Revenue growth 5Y31.19%
Sales Q2Q%34.58%
Revenue Next Year20.74%
Revenue Next 2Y19.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y236.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y373.22%
OCF growth 3YN/A
OCF growth 5YN/A